Continuing Education Evaluation

Continuing Education Evaluation

Save my progress and resume later | Resume a previously saved form

Resume Later

In order to be able to resume this form later, please enter your email and choose a password.

Your Email:

A Password:

Confirm Password:

Password must contain the following:

12 Characters
1 Uppercase letter
1 Lowercase letter
1 Number
1 Special character

Program Information

Program name

Program ID

Program Date of Completion

Participant Information

First Name

Last Name

E-mail

Country

State

Program Completion Time

Approximately how many hours did it take you to complete this program?

Please only consider hours spent actively completing course materials.

Learner Satisfaction

	Strongly Agree	Agree	Disagree	Strongly Disagree
I have gained knowledge that will improve patient care.
The learning assessment(s) accurately reflected the knowledge/skills I gained from this program.
The active learning techniques(1) were effective and appropriate.
The educational content was evidence-based citing the most current literature and/or treatment guidelines.
The program met my expectations.

(1) The active learning techniques employed by the program may include (but are not limited to) PlayPosit activities, Case Studies, and Multiple-Choice Assessments.

If "Disagree" or "Strongly Disagree", please identify any improvements that can be made to the program to support learners in gaining new knowledge.

If "Disagree" or "Strongly Disagree", please identify any lectures/material that did not provide adequate preparation for the learning assessment(s).

If "Other", please specify:

If "Disagree" or "Strongly Disagree", please identify the outdated educational content suggested for review.

If "Disagree" or "Strongly Disagree", please identify areas where expectations were not met.

Gap Analysis

Has participation in this program elicited any change(s) within your practice?

YesNo

If "Yes", please specify the change(s) you intend to make within your practice.

Please identify any barriers you perceive in implementing these changes (select all that apply).

If "Other", please specify.

How will you address these barriers to implement changes in knowledge and behavior?

What additional knowledge or skills are needed to implement changes in practice?

If "No", please explain.

An Introduction to Motivational Interviewing

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Summarize motivational interviewing terms and techniques
Describe areas where motivational interviewing is utilized in the pharmacist patient care process
Review motivational interviewing skills versus traditional counseling techniques
Utilize motivational interviewing techniques to guide conversations regarding patient behavior

If "Disagree" or "Strongly Disagree" was selected, please explain.

Management and Advancements for Alzheimer's Disease

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Describe the epidemiology and public impact of Alzheimer's disease
Summarize the pathophysiology of aging and Alzheimer's disease
Recognize risk factors for disease and measures for prevention
Distinguish clinical manifestations of the disease versus normal aging
Discuss strategies for individualized patient care
Describe pharmacologic and medical therapies available for Alzheimer’s disease
Identify new and emerging developments in disease management
Discuss factors regarding rehabilitation for patients with Alzheimer's disease
Provide support and resources for families and caregivers
Describe legal and ethical considerations in the management of Alzheimer’s disease

If "Disagree" or "Strongly Disagree" was selected, please explain.

Practical Management of Anticoagulation

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Discuss risk factors, presentation and locations of VTE
Discuss diagnostic methods of VTE
Recommend anticoagulation strategy for VTE and atrial fibrillation
Identify risk factors for complications of atrial fibrillation
Discuss indications and monitoring for warfarin related to diagnosis
Review dosing, drug and food interactions
Discuss the options for monitoring INR
Recognize approved protocols for switching between warfarin and DOACs
Review the various agents available, indications and monitoring for the various DOACs approved for use in the US
Discuss clinical pearls of use in patients with comorbid disease states
Recognize approved protocols for switching between DOACs and Warfarin
Discuss guidelines and recent literature regarding the periprocedural management of anticoagulation
Evaluate the risk of bleeding and the risk of thromboembolism in the periprocedural setting for a patient taking anticoagulation
Develop an individualized plan for the management of a patient’s anticoagulation around the time of a procedure.
Provide patient education with the goal to optimize therapy and reduce the risk of adverse events
Apply knowledge and principles taught in this program to patient cases in order to develop treatment plans

If "Disagree" or "Strongly Disagree" was selected, please explain.

Acute Pain Management

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Explain key differences between acute and chronic pain
Identify the types of pain based on a patient’s reports of symptoms
Explain the importance of proper assessment in pain management
Identify the consequences of untreated pain
Explain the concept of multimodal therapy for acute pain
List the common therapies used for acute pain
Recommend treatment and monitoring plans for patients with varying severities of acute non-surgical pain
List and compare the common multi-modal therapies used in the management of acute peri-operative pain
Describe the monitoring process for acute pain therapies
Identify concerns associated with procedural pain control
Describe the process of using Patient Controlled Analgesia (PCA) in acute pain

If "Disagree" or "Strongly Disagree" was selected, please explain.

Common Chronic Care Issues

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Describe metabolic syndrome as a cluster of several disorders that together raise the risk of individuals developing atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, and can lead to vascular and neurologic complications
Explain the prevalence of metabolic syndrome and epidemiological and statistical data
Discuss the rationale for the treatment and management of these related conditions to decrease the risk of metabolic complications and improve patient outcomes
Perform patient assessments
Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioner
Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice
Review updated definitions and goals from the 2017 AHA/ACC hypertension guidelines
Perform patient assessment for a patient with hypertension
Order, perform, and interpret clinical and laboratory testing for a patient with hypertension
Evaluate and manage hypertension, including drug therapy changes in collaboration with other health care providers
Identify potential complications associated with obesity
Analyze a patient to determine if they are a candidate for pharmacotherapy treatment of obesity
Recommend treatment options for obesity in both children and adults and discuss the risks and benefits of each treatment
Perform patient assessments for patients with Type 2 Diabetes Mellitus (T2DM)
Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice for patients with T2DM
Evaluate and manage T2DM, including appropriate drug therapy changes, in collaboration with other health care practitioners
Define continuous blood glucose monitoring and indications for use in patients with type 2 diabetes
Review glycemic treatment targets for patients with type 2 diabetes
Compare and contrast self-monitored blood glucose monitoring and continuous blood glucose monitoring
Summarize glucose monitoring devices available for blood glucose monitoring
Evaluate results of continuous blood glucose monitoring, including appropriate drug therapy changes, in collaboration with other health care practitioners

If "Disagree" or "Strongly Disagree" was selected, please explain.

Practical Management of Diabetes

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Discuss the pathophysiology of type I, type II and gestational diabetes
Discuss risk factors associated with diabetes
Recognize symptoms of diabetes
List Diabetes complications
Describe the mechanism of action of diabetes oral medications
Review dosing, efficacy, safety and drug interactions
Discuss the cardiovascular benefits of diabetes oral medications
Describe the mechanism of action of diabetes injectable medications
Explain the time to onset, peak and duration of action of medications
List common adverse effects and counseling points of injectable medications for management of diabetes
Explain common drug interactions of injectable products.
List the diagnosis criteria of diabetes
Discuss the treatment goals pertaining to patient’s specific conditions
Develop pharmacotherapy plan for management of type I diabetes
Adjust pharmacotherapy plan based on patient’s responses
Discuss the disease monitoring plan for effectiveness and complications
Review non-pharmacological strategies in preventing type II diabetes
Develop pharmacotherapy plan for management of type II diabetes
Adjust pharmacotherapy plan based on patient’s responses
Discuss the disease monitoring plan for effectiveness and complications
Apply knowledge and principles taught in this program to patient cases in order to develop and adjust the treatment plans.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Infectious Disease Update

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Identify the primary concerns for the spread of tuberculosis in a resident population
Describe the current treatment plan for tuberculosis
Assess the treatment needs for decubitus ulcers
Describe steps in the prevention and treatment of pneumococcal disease
Recommend alternative drugs when faced with resistant organisms
Describe the current therapeutics treatments for Hepatitis A and B
Detail the steps necessary when dealing with a Rotavirus/Norovirus outbreak
Describe the latest therapeutic choices for the treatment of HIV
Detail the latest vaccine schedule recommendations that would apply to the typical populations of residential care facilities.
Review the epidemiology of TB in the US based on the 2021 CDC data
Describe the emerging treatments for LTBI and for active disease.
Evaluate treatment regimens for infected decubitus ulcers
Discuss the treatment of pneumococcal disease
Describe the place in therapy of new antimicrobials
Recommend therapeutic options for multidrug-resistant Gram-negative organisms
Describe the current treatments and management for Hepatitis A and B
Detail the steps necessary when dealing with a Rotavirus/Norovirus outbreak
Describe the latest therapeutic choices for the treatment of HIV
Describe the current common vaccinations necessary for residential care facilities
Detail the CDC/ACIP process for review of the adult schedule
Describe some of the latest changes regarding vaccinations that might affect residential care patients

If "Disagree" or "Strongly Disagree" was selected, please explain.

Herbal & Dietary Supplement Use in Clinical Practice: A Primer for Pharmacists

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Describe the regulatory framework guiding current supplement labeling and manufacturing
Apply patient-focused communication strategies to reduce drug interactions
Evaluate and recommend appropriate use of HDS to different patient populations
Identify the limitations of HDS use as a part of complementary and integrative healthcare
Define the terms GMP, DER, standardization, homeopathy, dietary & herbal supplement
Identify HDS regulatory guidelines of clinical relevance
Choose an HDS based on quality indicators
Categorize clinical evidence for HDS effectiveness and potential for drug interactions
Describe the limited uses of the top ten HDS, their proposed pharmacological effects, and potential drug interactions
Select an adequate HDS approach to avoid drug interactions in patients on multiple medications
Apply knowledge and principles taught in this program to patient cases in order to improve the safe use of HDS as part of complementary and integrative healthcare practices

If "Disagree" or "Strongly Disagree" was selected, please explain.

The Management of Asthma

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Explain the terms used to characterize asthma (severity, control, impairment, risk) and the use of an Asthma Action Plan.
Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions.
Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications.
Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Treating and Managing Patients with Opioid and Other Substance Use Disorders

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Outline recommendations from evidence-based practice guidelines for opioid management for healthcare providers
Explain the importance of proper assessment in pain management and identify the consequences of untreated pain
List components of risk mitigation strategies in the practice of chronic pain management with specific focus on prescription drug monitoring programs, opioid risk assessment tools, and urinary drug screening tests
Recommend appropriate treatment options and monitoring strategies with opioids and nonopioids in chronic pain management
Formulate a general education outline and identify target factors which will be important for the patient during the opioid tapering process.
Recognize available devices, candidates, and educational points associated with naloxone therapy in the prevention of substance abuse overdose

If "Disagree" or "Strongly Disagree" was selected, please explain.

Endocrinology and Bone Health Conditions

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Interpret clinical and laboratory tests related to disease and medication management for common endocrinology and bone health conditions seen in the ambulatory care setting.
Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions for common endocrinology and bone health conditions seen in the ambulatory care setting.
Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications for common endocrinology and bone health conditions seen in the ambulatory care setting.
Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy for common endocrinology and bone health conditions seen in the ambulatory care setting.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Cardiovascular Conditions

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Interpret clinical and laboratory tests related to disease and medication management for common cardiovascular conditions seen in the ambulatory care setting.
Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions for common cardiovascular conditions seen in the ambulatory care setting.
Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications for common cardiovascular conditions seen in the ambulatory care setting.
Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy for common cardiovascular conditions seen in the ambulatory care setting.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Treating and Managing Infectious Diseases

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Interpret clinical and laboratory tests related to disease and medication management for common infectious diseases seen in the ambulatory care setting.
Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions for common infectious diseases seen in the ambulatory care setting.
Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications for common infectious diseases seen in the ambulatory care setting.
Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy for common infectious diseases seen in the ambulatory care setting.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Pulmonary Conditions

Did this program achieve the following overall learning objectives?

	Strongly Agree	Agree	Disagree	Strongly Disagree
Interpret clinical and laboratory tests related to disease and medication management for common pulmonary conditions seen in the ambulatory care setting.
Use clinical practice guidelines to establish goals of therapy, gaps in care, and appropriateness of pharmacological and nonpharmacological interventions for common pulmonary conditions seen in the ambulatory care setting.
Assess patient-specific information to create an individualized care plan including appropriateness, efficacy, and safety for drug therapy and lifestyle modifications for common pulmonary conditions seen in the ambulatory care setting.
Develop appropriate follow-up and monitoring strategies to evaluate patient response to drug therapy for common pulmonary conditions seen in the ambulatory care setting.

If "Disagree" or "Strongly Disagree" was selected, please explain.

Speaker Quality

	Strongly Agree	Agree	Disagree	Strongly Disagree
The speaker(s) engaged the audience.
The speaker(s) can be clearly heard and understood.
The speaker(s) was organized (the flow of information was easy to follow).
The speaker(s) uses simple language that is easily understood by the target audience.

Please identify any speaker(s) that need improvement and provide additional feedback where appropriate.

Please identify any speaker(s) that need improvement and provide additional feedback where appropriate..

Please identify any speaker(s) that need improvement and provide additional feedback where appropriate..

Please identify any speaker(s) that need improvement and provide additional feedback where appropriate.

Activity Bias

	Strongly Agree	Agree	Disagree	Strongly Disagree
The activity gave a balanced view of therapeutic options (1).
The activity promotes improvements in healthcare (2).
The speaker(s) provided a reasonable and valid interpretation of the information available on the subject (3).

(1) No single product or service is over represented in the educational activity when other equal but competing products or services are available for inclusion.

(2) Unscientific approaches to diagnosis or therapy, or recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients are excluded from the activity.

(3) The speaker(s) did NOT willfully misinterpret any information with the purpose of promoting any commercial entity or product.

Please identify the lecture and slide number(s) where a product or service has been over represented.

Please identify the lecture and slide number(s) where the activity content promotes any treatment that causes a deliberate risk to patient safety.

Please identify a specific speaker or set of speakers perceived to engage in willful misinterpretation of content.

Additional Feedback

Please provide any additional feedback you may have for this program. If you do not have any additional feedback, please enter "NA".

Does the UF Office of Continuing Pharmacy Education have your permission to use the above comments in future communications about this program?

YesNo

Save my progress and resume later | Resume a previously saved form

Contact Information